Rachel C. Morgan

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

David P. Dearnaley, Matthew R. Sydes, John D. Graham et al. · The Lancet Oncology · 2007 · 904 citations

Radiation Therapy, Medicine, Mrc Rt01 +8

Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial

Matthew R. Sydes, Mahesh Parmar, Nicholas D. James et al. · Trials · 2009 · 142 citations · Full text

Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): A new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy

Chris Parker, Matthew R. Sydes, Charles Catton et al. · British Journal of Urology · 2007 · 138 citations

Urology, Surgical Oncology, Radiation Medicine +8

Dose–Volume Constraints to Reduce Rectal Side Effects From Prostate Radiotherapy: Evidence From MRC RT01 Trial ISRCTN 47772397

S. Gulliford, Kerwyn Foo, Rachel C. Morgan et al. · International Journal of Radiation Oncology*Biology*Physics · 2009 · 131 citations · Full text

Urology, Radiation Medicine, Radiation Therapy +6

Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi‐arm, multistage randomized controlled trial

Nicholas D. James, Matthew R. Sydes, Noel W. Clarke et al. · British Journal of Urology · 2008 · 97 citations

Metastatic Prostate Cancer, Urology, Medicine +15